Loading...Loading...Regence medical policies are evidence-based and take into account the available scientific evidence published in peer-reviewed journals, as well as evidence-based clinical practice guidelines and specialty society statements. The process for Regence medical policy development is described in the Introduction to the Regence Medical Policy Manual.
In addition, Regence values the experience and opinions of practicing physicians and other health care providers. Your feedback on our policies is welcome and is an important part of our annual policy review process.
You may provide feedback to us on the following policies by:
- Responding to the email that directed you to this page. Please be sure to identify the policy you are providing comments on in your email response.
Contacting Medical Policy Staff. Please be sure to identify the policy in the policy name field, as well as your name, specialty and contact information. (Note: contact information only needs to be included if you do not regularly receive medical policy email notification from Regence.)
Bariatric - (1)
- Gastric Electrical Stimulation, Surgery #111
Behavioral Health - (2)
- Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder, Behavioral Health #18
- Applied Behavior Analysis Initial Assessment for the Treatment of Autism Spectrum Disorder, Behavioral Health #33
Cardiology - (3)
- Signal-Averaged Electrocardiography (SAECG), Medicine #21
- Cardiac Hemodynamic and Thoracic Fluid Index Monitoring for the Management of Heart Failure in the Outpatient Setting, Medicine #33
- Spinal Cord and Dorsal Root Ganglion Stimulation, Surgery #45
Endocrinology - (1)
- Gastric Electrical Stimulation, Surgery #111
Gastroenterology - (2)
- Measurement of Serum Antibodies to Selected Biologic Agents, Laboratory #65
- Gastric Electrical Stimulation, Surgery #111
General Surgery - (4)
- Percutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty, Surgery #107
- Ovarian, Internal Iliac, and Gonadal Vein Embolization, Ablation, and Sclerotherapy, Surgery #147
Genetics - (7)
- Topographic Genotyping to Classify Cancer Risk, Genetic Testing #16
- Gene Expression Profiling for Melanoma, Genetic Testing #29
- Genetic Testing for CADASIL Syndrome, Genetic Testing #51
- Chromosomal Microarray Analysis (CMA) or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay, Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies, Genetic Testing #58
- Invasive Prenatal Fetal Diagnostic Testing for Chromosomal Abnormalities, Genetic Testing #78
- Genetic Testing for the Evaluation of Products of Conception and Pregnancy Loss, Genetic Testing #79
- Expanded Molecular Testing of Cancers to Select Targeted Therapies, Genetic Testing #83
Hematology Oncology - (3)
- Expanded Molecular Testing of Cancers to Select Targeted Therapies, Genetic Testing #83
- Hematopoietic Cell Transplantation for Autoimmune Diseases, Transplant #45.32
- Hematopoietic Cell Transplantation for Light-Chain (AL) Amyloidosis or Waldenstrom Macroglobulinemia, Transplant #45.40
Infertility - (1)
- Gene Expression Profiling for Melanoma, Genetic Testing #29
Neurology - (4)
- Genetic Testing for CADASIL Syndrome, Genetic Testing #51
- Spinal Cord and Dorsal Root Ganglion Stimulation, Surgery #45
- Vagus Nerve Stimulation, Surgery #74
- Percutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty, Surgery #107
Neurosurgery - (2)
- Spinal Cord and Dorsal Root Ganglion Stimulation, Surgery #45
- Vagus Nerve Stimulation, Surgery #74
Obstetrics and Gynecology - (4)
- Gene Expression Profiling for Melanoma, Genetic Testing #29
- Invasive Prenatal Fetal Diagnostic Testing for Chromosomal Abnormalities, Genetic Testing #78
- Genetic Testing for the Evaluation of Products of Conception and Pregnancy Loss, Genetic Testing #79
- Ovarian, Internal Iliac, and Gonadal Vein Embolization, Ablation, and Sclerotherapy, Surgery #147
Oncology - (4)
- Topographic Genotyping to Classify Cancer Risk, Genetic Testing #16
- Expanded Molecular Testing of Cancers to Select Targeted Therapies, Genetic Testing #83
- Hematopoietic Cell Transplantation for Autoimmune Diseases, Transplant #45.32
- Hematopoietic Cell Transplantation for Light-Chain (AL) Amyloidosis or Waldenstrom Macroglobulinemia, Transplant #45.40
Orthopedics - (1)
- Ultrasonic Bone Growth Stimulators (Osteogenic Stimulation), Durable Medical Equipment #83.12
Pediatrics - (2)
- Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder, Behavioral Health #18
- Chromosomal Microarray Analysis (CMA) or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay, Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies, Genetic Testing #58
Physical Medicine - (1)
- Spinal Cord and Dorsal Root Ganglion Stimulation, Surgery #45
Primary Care - (5)
- Genetic Testing for CADASIL Syndrome, Genetic Testing #51
- Chromosomal Microarray Analysis (CMA) or Copy Number Analysis for the Genetic Evaluation of Patients with Developmental Delay, Intellectual Disability, Autism Spectrum Disorder, or Congenital Anomalies, Genetic Testing #58
- Measurement of Serum Antibodies to Selected Biologic Agents, Laboratory #65
- Cardiac Hemodynamic and Thoracic Fluid Index Monitoring for the Management of Heart Failure in the Outpatient Setting, Medicine #33
- Vagus Nerve Stimulation, Surgery #74
Psychiatry - (2)
- Applied Behavior Analysis for the Treatment of Autism Spectrum Disorder, Behavioral Health #18
- Vagus Nerve Stimulation, Surgery #74
Radiology - (2)
- Percutaneous Vertebroplasty, Kyphoplasty, Sacroplasty, and Coccygeoplasty, Surgery #107
- Ovarian, Internal Iliac, and Gonadal Vein Embolization, Ablation, and Sclerotherapy, Surgery #147
- Hematopoietic Cell Transplantation for Autoimmune Diseases, Transplant #45.32
- Hematopoietic Cell Transplantation for Light-Chain (AL) Amyloidosis or Waldenstrom Macroglobulinemia, Transplant #45.40
Rheumatology - (1)
- Measurement of Serum Antibodies to Selected Biologic Agents, Laboratory #65